Digestive & Intestinal Remedies Market By Type (Digestive Medicines, Gastrointestinal Agents and Remedies), By Age Group (Pediatirc, Adult), By Distribution Channel (Online, Offline): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global digestive and intestinal remedies market was valued at $18,250.0 million in 2021, and is projected to reach $26,243.4 million by 2031, registering a CAGR of 3.6% from 2022 to 2031.
Gastrointestinal conditions are disorders of digestive system, an extensive and complex system that breaks down food in order to absorb water and extract nutrients, minerals and vitamins for the body’s use, while removing unabsorbed waste. Symptoms of digestive disorders vary from condition to condition. Some of the common symptoms for most gastrointestinal problems include abdominal discomfort, unintentional weight loss, acid reflux, diarrhea, constipation, and fecal incontinence. Prevalence of these symptoms increases demand for various options for treatment. For instance, according to data by the Centers for Disease Control and Prevention in 2018, the estimated number of adults diagnosed with ulcers was 14.8 million, which is a 5.9% of total population. Moreover, in 2018, the number of visits to physician offices with diseases of digestive system as a primary diagnosis was about 37.2 million. The symptoms for this disease can be well treated by medicines such as laxatives, antacids, acidifying agents, and may also need use of digestive enzymes as a part of treatment.
The global digestive and intestinal remedies market is anticipated to show significant growth during the forecast period, owing to increase in gastrointestinal disorders, changes in natural food habits, and high demand for related over-the-counter products. Furthermore, increase in prevalence of digestive diseases such as inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness and increase in healthcare expenditure considerably contribute toward the market growth. However, increase in consumption of supplementary food products and availability of alternative therapies for gastrointestinal diseases negatively impact the market growth. In addition, economic growth in emerging markets offers lucrative opportunities for growth of the market.
The global digestive and intestinal remedies market is segmented on the basis of type, age group, distribution channel, and region. By type, the market is classified into digestive medicines and gastrointestinal agents & remedies. Furthermore, the digestive medicines segment is sub-classified into online and offline. The gastrointestinal agents & remedies segment is sub-classified into online and offline. By age group, the market is classified into pediatric and adult. By distribution channel, it is classified into online and offline. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline Plc, Jiangzhong Pharmaceutical Co Ltd, Johnson & Johnson, Menarini Group, Merck KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group Plc, Sanofi S.A., Taisho Pharmaceutical Holdings Co Ltd, and Takeda Pharmaceutical Company Limited.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive & intestinal remedies market analysis from 2021 to 2031 to identify the prevailing digestive & intestinal remedies market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the digestive & intestinal remedies market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global digestive & intestinal remedies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Digestive Medicines
Gastrointestinal Agents and Remedies
By Age Group
Pediatirc
Adult
By Distribution Channel
Online
Offline
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
Bausch Health Companies Inc.
Bayer AG
Boehringer Ingelheim International GmbH
Eli Lilly and Company
Glaxosmithkline plc
Jiangzhong Pharmaceutical Co Ltd
Johnson & Johnson
Menarini Group
Merck KGaA
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Procter & Gamble Company
Reckitt Benckiser Group plc
Sanofi S.A.
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Company Limited
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Digestive Medicines
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Gastrointestinal Agents and Remedies
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Pediatirc
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Adult
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Online
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Offline
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: DIGESTIVE & INTESTINAL REMEDIES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Age Group
- 7.2.4 North America Market size and forecast, by Distribution Channel
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Age Group
- 7.2.5.1.3 Market size and forecast, by Distribution Channel
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Age Group
- 7.2.5.2.3 Market size and forecast, by Distribution Channel
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Age Group
- 7.2.5.3.3 Market size and forecast, by Distribution Channel
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Age Group
- 7.3.4 Europe Market size and forecast, by Distribution Channel
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Age Group
- 7.3.5.1.3 Market size and forecast, by Distribution Channel
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Age Group
- 7.3.5.2.3 Market size and forecast, by Distribution Channel
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Age Group
- 7.3.5.3.3 Market size and forecast, by Distribution Channel
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Age Group
- 7.3.5.4.3 Market size and forecast, by Distribution Channel
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Age Group
- 7.3.5.5.3 Market size and forecast, by Distribution Channel
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Age Group
- 7.3.5.6.3 Market size and forecast, by Distribution Channel
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Age Group
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Age Group
- 7.4.5.1.3 Market size and forecast, by Distribution Channel
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Age Group
- 7.4.5.2.3 Market size and forecast, by Distribution Channel
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Age Group
- 7.4.5.3.3 Market size and forecast, by Distribution Channel
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Age Group
- 7.4.5.4.3 Market size and forecast, by Distribution Channel
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Age Group
- 7.4.5.5.3 Market size and forecast, by Distribution Channel
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Age Group
- 7.4.5.6.3 Market size and forecast, by Distribution Channel
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Age Group
- 7.5.4 LAMEA Market size and forecast, by Distribution Channel
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Age Group
- 7.5.5.1.3 Market size and forecast, by Distribution Channel
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Age Group
- 7.5.5.2.3 Market size and forecast, by Distribution Channel
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Age Group
- 7.5.5.3.3 Market size and forecast, by Distribution Channel
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Age Group
- 7.5.5.4.3 Market size and forecast, by Distribution Channel
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Abbott Laboratories
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Bausch Health Companies Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Bayer AG
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Boehringer Ingelheim International GmbH
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Eli Lilly and Company
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Glaxosmithkline plc
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Jiangzhong Pharmaceutical Co Ltd
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Johnson & Johnson
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Menarini Group
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Merck KGaA
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Pfizer Inc.
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Prestige Consumer Healthcare Inc.
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Procter & Gamble Company
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Reckitt Benckiser Group plc
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Sanofi S.A.
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Taisho Pharmaceutical Holdings Co Ltd
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Takeda Pharmaceutical Company Limited
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR DIGESTIVE MEDICINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR DIGESTIVE MEDICINES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR GASTROINTESTINAL AGENTS AND REMEDIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR GASTROINTESTINAL AGENTS AND REMEDIES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 7. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR PEDIATIRC, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR PEDIATIRC BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR ADULT, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR ADULT BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. GLOBAL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 12. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR ONLINE, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR ONLINE BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. DIGESTIVE & INTESTINAL REMEDIES MARKET SIZE, FOR OFFLINE, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. DIGESTIVE & INTESTINAL REMEDIES MARKET FOR OFFLINE BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. NORTH AMERICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 18. NORTH AMERICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 19. NORTH AMERICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 20. NORTH AMERICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. U.S. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 22. U.S. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 23. U.S. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 24. CANADA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 25. CANADA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 26. CANADA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 27. MEXICO DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 28. MEXICO DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 29. MEXICO DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 30. EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 31. EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 32. EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 33. EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 34. GERMANY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 35. GERMANY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 36. GERMANY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 37. FRANCE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 38. FRANCE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 39. FRANCE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 40. U.K. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 41. U.K. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 42. U.K. DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 43. ITALY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 44. ITALY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 45. ITALY DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 46. SPAIN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 47. SPAIN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 48. SPAIN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 49. REST OF EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. REST OF EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 51. REST OF EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 52. ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 53. ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 54. ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 55. ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 56. JAPAN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 57. JAPAN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 58. JAPAN DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 59. CHINA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 60. CHINA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 61. CHINA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 62. INDIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 63. INDIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 64. INDIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 65. AUSTRALIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 66. AUSTRALIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 67. AUSTRALIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 68. SOUTH KOREA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. SOUTH KOREA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 70. SOUTH KOREA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 74. LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 76. LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 77. LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 78. BRAZIL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 79. BRAZIL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 80. BRAZIL DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 81. SAUDI ARABIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 82. SAUDI ARABIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 83. SAUDI ARABIA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 84. SOUTH AFRICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 85. SOUTH AFRICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 86. SOUTH AFRICA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 87. REST OF LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 88. REST OF LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 89. REST OF LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 90.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 91.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 92.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 93.ABBOTT LABORATORIES: NET SALES,
- TABLE 94.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 95.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
- TABLE 96.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
- TABLE 97.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
- TABLE 98.BAUSCH HEALTH COMPANIES INC.: NET SALES,
- TABLE 99.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
- TABLE 100.BAYER AG: COMPANY SNAPSHOT
- TABLE 101.BAYER AG: OPERATING SEGMENTS
- TABLE 102.BAYER AG: PRODUCT PORTFOLIO
- TABLE 103.BAYER AG: NET SALES,
- TABLE 104.BAYER AG: KEY STRATERGIES
- TABLE 105.BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
- TABLE 106.BOEHRINGER INGELHEIM INTERNATIONAL GMBH: OPERATING SEGMENTS
- TABLE 107.BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
- TABLE 108.BOEHRINGER INGELHEIM INTERNATIONAL GMBH: NET SALES,
- TABLE 109.BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY STRATERGIES
- TABLE 110.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
- TABLE 111.ELI LILLY AND COMPANY: OPERATING SEGMENTS
- TABLE 112.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
- TABLE 113.ELI LILLY AND COMPANY: NET SALES,
- TABLE 114.ELI LILLY AND COMPANY: KEY STRATERGIES
- TABLE 115.GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
- TABLE 116.GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
- TABLE 117.GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
- TABLE 118.GLAXOSMITHKLINE PLC: NET SALES,
- TABLE 119.GLAXOSMITHKLINE PLC: KEY STRATERGIES
- TABLE 120.JIANGZHONG PHARMACEUTICAL CO LTD: COMPANY SNAPSHOT
- TABLE 121.JIANGZHONG PHARMACEUTICAL CO LTD: OPERATING SEGMENTS
- TABLE 122.JIANGZHONG PHARMACEUTICAL CO LTD: PRODUCT PORTFOLIO
- TABLE 123.JIANGZHONG PHARMACEUTICAL CO LTD: NET SALES,
- TABLE 124.JIANGZHONG PHARMACEUTICAL CO LTD: KEY STRATERGIES
- TABLE 125.JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 126.JOHNSON & JOHNSON: OPERATING SEGMENTS
- TABLE 127.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 128.JOHNSON & JOHNSON: NET SALES,
- TABLE 129.JOHNSON & JOHNSON: KEY STRATERGIES
- TABLE 130.MENARINI GROUP: COMPANY SNAPSHOT
- TABLE 131.MENARINI GROUP: OPERATING SEGMENTS
- TABLE 132.MENARINI GROUP: PRODUCT PORTFOLIO
- TABLE 133.MENARINI GROUP: NET SALES,
- TABLE 134.MENARINI GROUP: KEY STRATERGIES
- TABLE 135.MERCK KGAA: COMPANY SNAPSHOT
- TABLE 136.MERCK KGAA: OPERATING SEGMENTS
- TABLE 137.MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 138.MERCK KGAA: NET SALES,
- TABLE 139.MERCK KGAA: KEY STRATERGIES
- TABLE 140.PFIZER INC.: COMPANY SNAPSHOT
- TABLE 141.PFIZER INC.: OPERATING SEGMENTS
- TABLE 142.PFIZER INC.: PRODUCT PORTFOLIO
- TABLE 143.PFIZER INC.: NET SALES,
- TABLE 144.PFIZER INC.: KEY STRATERGIES
- TABLE 145.PRESTIGE CONSUMER HEALTHCARE INC.: COMPANY SNAPSHOT
- TABLE 146.PRESTIGE CONSUMER HEALTHCARE INC.: OPERATING SEGMENTS
- TABLE 147.PRESTIGE CONSUMER HEALTHCARE INC.: PRODUCT PORTFOLIO
- TABLE 148.PRESTIGE CONSUMER HEALTHCARE INC.: NET SALES,
- TABLE 149.PRESTIGE CONSUMER HEALTHCARE INC.: KEY STRATERGIES
- TABLE 150.PROCTER & GAMBLE COMPANY: COMPANY SNAPSHOT
- TABLE 151.PROCTER & GAMBLE COMPANY: OPERATING SEGMENTS
- TABLE 152.PROCTER & GAMBLE COMPANY: PRODUCT PORTFOLIO
- TABLE 153.PROCTER & GAMBLE COMPANY: NET SALES,
- TABLE 154.PROCTER & GAMBLE COMPANY: KEY STRATERGIES
- TABLE 155.RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT
- TABLE 156.RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
- TABLE 157.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
- TABLE 158.RECKITT BENCKISER GROUP PLC: NET SALES,
- TABLE 159.RECKITT BENCKISER GROUP PLC: KEY STRATERGIES
- TABLE 160.SANOFI S.A.: COMPANY SNAPSHOT
- TABLE 161.SANOFI S.A.: OPERATING SEGMENTS
- TABLE 162.SANOFI S.A.: PRODUCT PORTFOLIO
- TABLE 163.SANOFI S.A.: NET SALES,
- TABLE 164.SANOFI S.A.: KEY STRATERGIES
- TABLE 165.TAISHO PHARMACEUTICAL HOLDINGS CO LTD: COMPANY SNAPSHOT
- TABLE 166.TAISHO PHARMACEUTICAL HOLDINGS CO LTD: OPERATING SEGMENTS
- TABLE 167.TAISHO PHARMACEUTICAL HOLDINGS CO LTD: PRODUCT PORTFOLIO
- TABLE 168.TAISHO PHARMACEUTICAL HOLDINGS CO LTD: NET SALES,
- TABLE 169.TAISHO PHARMACEUTICAL HOLDINGS CO LTD: KEY STRATERGIES
- TABLE 170.TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
- TABLE 171.TAKEDA PHARMACEUTICAL COMPANY LIMITED: OPERATING SEGMENTS
- TABLE 172.TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
- TABLE 173.TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET SALES,
- TABLE 174.TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.DIGESTIVE & INTESTINAL REMEDIES MARKET SEGMENTATION
- FIGURE 2.DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031
- FIGURE 3.DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.DIGESTIVE & INTESTINAL REMEDIES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.DIGESTIVE & INTESTINAL REMEDIES MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGESTIVE MEDICINES DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GASTROINTESTINAL AGENTS AND REMEDIES DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 15.DIGESTIVE & INTESTINAL REMEDIES MARKET,BY AGE GROUP,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PEDIATIRC DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ADULT DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 18.DIGESTIVE & INTESTINAL REMEDIES MARKET,BY DISTRIBUTION CHANNEL,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ONLINE DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OFFLINE DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031(%)
- FIGURE 21.DIGESTIVE & INTESTINAL REMEDIES MARKET BY REGION,2021
- FIGURE 22.U.S. DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 23.CANADA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 24.MEXICO DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 25.GERMANY DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 26.FRANCE DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 27.U.K. DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 28.ITALY DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 29.SPAIN DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 30.REST OF EUROPE DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 31.JAPAN DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 32.CHINA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 33.INDIA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 34.AUSTRALIA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 35.SOUTH KOREA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 36.REST OF ASIA-PACIFIC DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 37.BRAZIL DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 38.SAUDI ARABIA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH AFRICA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF LAMEA DIGESTIVE & INTESTINAL REMEDIES MARKET,2021-2031($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45.COMPETITIVE DASHBOARD
- FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 48.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
- FIGURE 49.BAYER AG.: NET SALES ,($MILLION)
- FIGURE 50.BOEHRINGER INGELHEIM INTERNATIONAL GMBH.: NET SALES ,($MILLION)
- FIGURE 51.ELI LILLY AND COMPANY.: NET SALES ,($MILLION)
- FIGURE 52.GLAXOSMITHKLINE PLC.: NET SALES ,($MILLION)
- FIGURE 53.JIANGZHONG PHARMACEUTICAL CO LTD.: NET SALES ,($MILLION)
- FIGURE 54.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
- FIGURE 55.MENARINI GROUP.: NET SALES ,($MILLION)
- FIGURE 56.MERCK KGAA.: NET SALES ,($MILLION)
- FIGURE 57.PFIZER INC..: NET SALES ,($MILLION)
- FIGURE 58.PRESTIGE CONSUMER HEALTHCARE INC..: NET SALES ,($MILLION)
- FIGURE 59.PROCTER & GAMBLE COMPANY.: NET SALES ,($MILLION)
- FIGURE 60.RECKITT BENCKISER GROUP PLC.: NET SALES ,($MILLION)
- FIGURE 61.SANOFI S.A..: NET SALES ,($MILLION)
- FIGURE 62.TAISHO PHARMACEUTICAL HOLDINGS CO LTD.: NET SALES ,($MILLION)
- FIGURE 63.TAKEDA PHARMACEUTICAL COMPANY LIMITED.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook